Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
36 hedge funds and large institutions have $6.14M invested in Lumos Pharma, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 36 → 36 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
18% less capital invested
Capital invested by funds: $7.52M → $6.14M (-$1.38M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$111K |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
+$45.7K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$41.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$39.4K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$12.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Blackstone Inc
New York
|
-$735K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$59.3K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$13.2K |
| 4 |
Two Sigma Investments
New York
|
-$11.3K |
| 5 |
Renaissance Technologies
New York
|
-$10.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $10.5K | +$10.8K | +3,659 | +4,945% |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $7.59K | +$3.31K | +1,117 | +71% |
|
28
Bank of America
Charlotte,
North Carolina
| $5.08K | – | – | – |
|
|
WFA
29
West Financial Advisors
Des Moines,
Iowa
| $2.21K | – | – | – |
|
30
Morgan Stanley
New York
| $468 | -$492 | -166 | -50% |
|
|
31
Osaic Holdings
Scottsdale,
Arizona
| $435 | -$13.2K | -4,456 | -97% |
|
32
Group One Trading
Chicago,
Illinois
| $423 | – | – | – |
|
33
JP Morgan Chase
New York
| $116 | +$9 | +3 | +8% |
|
|
GRP
34
Global Retirement Partners
San Rafael,
California
| $31 | – | – | – |
|
35
Qube Research & Technologies (QRT)
London,
United Kingdom
| $8 | – | – | – |
|
|
CCMW
36
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
| – | -$318 | -100 | Closed |
|
37
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$130 | -41 | Closed |
|
LUMO Hedge Fund Activity: Q1 2024 in Review
36 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q1 2024, worth a combined $6.14M — down 18% from $7.52M a quarter earlier.
Fund positioning in LUMO was balanced in Q1 2024: 2 funds opened new positions, 2 closed out, 8 added to existing stakes and 8 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $111K. The largest seller was Blackstone Inc, cutting an estimated $735K.
- 36 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $6.14M of Lumos Pharma, Inc. Common Stock stock for Q1 2024, down 18% quarter-over-quarter.
- 2 funds opened new Lumos Pharma, Inc. Common Stock positions in Q1 2024 and 2 closed out, a net change of 0 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q1 2024 was Millennium Management, an estimated $111K added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q1 2024 was Blackstone Inc, an estimated $735K sold.
Based on aggregated 13F filings for Q1 2024.